Global Patent Index - EP 2285383 A2

EP 2285383 A2 20110223 - SEQUENTIAL ADMINISTRATION OF 20,20,21,21-PENTAFLUORO-17-HYDROXY-11 -Ý4-(HYDROXYACETYL) PHENYL¨-19-NOR-17 -PREGNA-4,9-DIENE-3-ONE AND ONE OR MORE PROGESTATIONAL HORMONES FOR TREATING GYNAECOLOGICAL DISEASES

Title (en)

SEQUENTIAL ADMINISTRATION OF 20,20,21,21-PENTAFLUORO-17-HYDROXY-11 -Ý4-(HYDROXYACETYL) PHENYL¨-19-NOR-17 -PREGNA-4,9-DIENE-3-ONE AND ONE OR MORE PROGESTATIONAL HORMONES FOR TREATING GYNAECOLOGICAL DISEASES

Title (de)

SEQUENTIELLE VERARBEITUNG VON 20,20,21,21-PENTAFLUOR-17-HYDROXY-11 -Ý4-(HYDROXYACETYL) PHENYL¨-19-NOR-17 -PREGNA-4,9-DIEN-3-ON UND EINEM ODER MEHREREN GESTAGENEN ZUR BEHANDLUNG GYNÄKOLOGISCHER ERKRANKUNGEN

Title (fr)

ADMINISTRATION SÉQUENTIELLE DE 20,20,21,21-PENTAFLUORO-17-HYDROXY-11 -Ý4-(HYDROXYACÉTYL)PHÉNYL-19-NOR-17 -PREGNA-4,9-DIÈNE-3-ONE ET D'UN OU PLUSIEURS PROGESTATIFS POUR TRAITER DES TROUBLES GYNÉCOLOGIQUES

Publication

EP 2285383 A2 20110223 (DE)

Application

EP 09745520 A 20090507

Priority

  • EP 2009003249 W 20090507
  • EP 08075496 A 20080514
  • US 7172508 P 20080514
  • EP 09745520 A 20090507

Abstract (en)

[origin: EP2123279A1] Pharmaceutical combination preparation comprises single dose units of the progesterone receptor antagonists of 20,20,21,21,21-pentafluoro-17-hydroxy-11beta -[4-(hydroxyacetyl)phenyl]-19-nor-17alpha -pregna-4,9-dien-3-one (I) and individual dosage units of a gestagen to its sequential, oral administration for the treatment of gynecological diseases. An independent claim is included for a pharmaceutical preparation comprising (I), and information and direction for use, which is to begin with the next treatment cycle or after the onset of menstrual bleeding. ACTIVITY : Gynecological; Cytostatic. MECHANISM OF ACTION : Progesterone receptor antagonist.

IPC 8 full level

A61K 31/567 (2006.01); A61P 5/34 (2006.01); A61P 5/36 (2006.01)

CPC (source: EP US)

A61K 31/567 (2013.01 - EP US); A61K 31/57 (2013.01 - EP US); A61K 31/585 (2013.01 - EP US); A61P 5/34 (2017.12 - EP); A61P 5/36 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP)

Citation (search report)

See references of WO 2009138186A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA RS

DOCDB simple family (publication)

EP 2123279 A1 20091125; CA 2724030 A1 20091119; EP 2285383 A2 20110223; JP 2011520820 A 20110721; US 2011112057 A1 20110512; WO 2009138186 A2 20091119; WO 2009138186 A3 20100114

DOCDB simple family (application)

EP 08075496 A 20080514; CA 2724030 A 20090507; EP 09745520 A 20090507; EP 2009003249 W 20090507; JP 2011508823 A 20090507; US 99212709 A 20090507